comparemela.com

Latest Breaking News On - Head of early development - Page 1 : comparemela.com

Azzur Group Appoints Senior Executive, Sarah Stevens, Ph D , as President of Azzur Labs & Azzur Cleanrooms on Demand™

/PRNewswire/ Azzur Group today announces the appointment of Sarah Stevens, to President of Azzur Labs and Azzur Cleanrooms on Demand™ (COD). In this new.

United statesUnited kingdomSan diegoSarah stevensBryan ottHead of early developmentQuotient sciencesUniversity of strathclyde glasgowAzzur groupAlbany molecular research incUniversity of manchesterMaster of business administrationAzzur labsAzzur cleanroomsSenior vice presidentEarly development

Azzur Group Appoints Senior Executive, Sarah Stevens, Ph D , as President of Azzur Labs & Azzur Cleanrooms on Demand™

BioPharma

United statesSan diegoUnited kingdomBryan ottSarah stevensMaster of business administrationQuotient sciencesAlbany molecular research incHead of early developmentAzzur groupUniversity of manchesterUniversity of strathclyde glasgowAzzur labsAzzur cleanroomsSenior vice presidentEarly development

Circle Pharma strengthens its executive leadership team with two senior appointments in Clinical Development

Press Release Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, announced today the appointments of Michael Cox, PharmD., MHSc, BCOP as senior vice president, head of Early Development, and…

North carolinaUnited statesMemorial sloan kettering cancer centerNew yorkDuke universityRoslyn pattersonEdward garmeyLos angelesDavid earpMichael coxEli lillyH iv researchPediatric clinical developmentHead of early developmentMount sinai medical centerOhio northern university

M3 WAKE RESEARCH POISED TO EXPAND PHASE I TRIAL SERVICES

/PRNewswire/ M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America s largest providers of Phase I-IV.

Soult ukpyolsiSouth koreaUnited statesFrance generalUnited kingdomCity ofWake researchWake research incTokyo stock exchangeHead of early developmentNew executive role will lead growthPhasei trial operations beyondNorth americaLucian cappoliEarly developmentPhasei operations

IDEAYA Biosciences Appoints Darrin M Beaupre, M D , Ph D , as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and.

Darrinm beaupreYujiros hataHead of researchH lee moffitt cancer centerMd anderson cancer centerHead of early developmentExchange commissionHead of early oncology developmentBiosciences incResearch instituteClinical research at pfizer incUniversity of miamiDevelopment in oncologyClinical research at pfizerFormer senior vice presidentEarly oncology development

vimarsana © 2020. All Rights Reserved.